Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Role of Statins in the Clinical and Radiologic Outcomes of Patients With Unruptured Intracranial Aneurysm Undergoing Microsurgery or Endovascular Treatment: A Systematic Review and Meta-Analysis Publisher Pubmed



Habibi MA1 ; Naseri Alavi SA2 ; Mirjnani MS3 ; Aliasgary A3 ; Delbari P4 ; Ahmadvand MH4 ; Hatami S5 ; Hasan Z6 ; Dmytriw AA6 ; Kobets AJ7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Neurosurgery, School of Medicine, Emory University, Atlanta, GA, United States
  3. 3. Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran
  4. 4. Student Research Committee, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  6. 6. Neuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
  7. 7. Department of Neurological Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States

Source: World Neurosurgery Published:2025


Abstract

Background: The impact of statin pretreatment on outcomes for patients undergoing endovascular treatment of intracranial aneurysms remains uncertain. We aimed to conduct a systematic review and meta-analysis evaluating the efficacy and safety of statins in this population. Methods: We searched the PubMed/MEDLINE, Embase, Scopus, and Web of Science databases from inception to August 1, 2024. This study compares the outcomes between statin users and nonusers undergoing endovascular aneurysm treatment. Results: Eight studies with 5862 patients were included. Complete occlusion rates after endovascular aneurysm treatment were similar between statin users and nonusers (pooled odds ratio [OR], 0.93; 95% confidence interval [CI], 0.70–1.23). Statin use was associated with a significantly increased risk of ischemic stroke (pooled OR, 1.51; 95% CI, 1.03–2.19, P = 0.03). No differences were seen in neurologic mortality (pooled OR, 0.74; 95% CI, 0.21–2.57; P = 0.63), all-cause mortality (pooled OR, 0.68; 95% CI, 0.16–2.90, P = 0.61), or retreatment rates (pooled OR, 0.76; 95% CI, 0.35–1.66; P = 0.49). Statin therapy was associated with decreased hemorrhagic complication (pooled OR, 0.45; 95% CI, 0.24–0.85; P = 0.01) but did not affect thrombosis risk (pooled OR, 1.28; 95% CI, 0.68–2.40; P = 0.45) and statin use decreased in-stent stenosis (OR, 2.31, 95% CI, 1.51–3.52; P = 0.001). Conclusions: Statin pretreatment may decrease the risk of hemorrhagic complications and in-stent stenosis after endovascular aneurysm therapy but does not improve angiographic occlusion. An increased hazard of ischemic events was found. Further data are needed to validate these findings and clarify the role of statins in patients with aneurysms undergoing endovascular procedures. © 2024 The Author(s)
Related Docs
1. Present Rationale and Future Directions for Intracranial Aneurysm Screening and Rupture Risk Prediction: The Road to Precision Surgery for Intracranial Aneurysms, Advanced Technologies in Vascular Neurosurgery: Techniques, Controversies and New Paradigms (2025)
2. Prediction of Cerebral Aneurysm Rupture Risk by Machine Learning Algorithms: A Systematic Review and Meta-Analysis of 18,670 Participants, Neurosurgical Review (2024)
3. Impact of Smoking on the Detection of Brain Aneurysms in General Population Screening: A Systematic Review and Meta-Analysis, Journal of Neurosurgery (2025)
Experts (# of related papers)
Milad Shafizadeh (1)